<img alt="" src="https://secure.perk0mean.com/184386.png" style="display:none;">

Pharmaceutical Supply Chain & Distribution Center Contingencies During COVID-19:
Collaborative Learning Q&A

Listen to a Q&A with Patrick Girten Manager, Quality Distribution US/PR, Bristol Myers Squibb, & Michael Hollweck, Senior Manager QA Logistics Americas, Celgene about how their supply chains were affected by COVID-19, including:

  • Precautionary DC operations during COVID
  • Creating redundancy in distribution with secondary sites and logistics providers
  • Approving new contingency routes
  • Shipping cross borders and customs
  • Virtual audits—is this a viable future for pharmaceutical QA supply chains?
Thumbnail_Pharmaceutical Supply Chain & Distribution Center Contingencies During COVID-19_EN

ELPRO is committed to protecting and respecting your privacy. Please tick below to agree to receive marketing messages from us that may be relevant to you. You can unsubscribe from these communications at any time. 

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

By clicking submit below, you consent to allow ELPRO to store and process the personal information submitted above to provide you the content requested.

we prove it.

group-2

Copyright © ELPRO-BUCHS AG. All Rights Reserved.